Search Protocols under revision. Back New search Go to resultsDiseaseMain groupCross-Sectional, Transplantation, Cellular TherapySolid TumorsProtocol groupHead and Neck OncologyradiotherapyDiseaseSalivary Gland TumorSubgroupICD10C08.-MeSHSalivary Gland NeoplasmsSequenceAntineoplastic therapySubstanceCisplatinSubstanceCisplatinSubstanceCisplatinSubstanceCisplatinNo. Substances1 RadiotherapySupportive therapySubstanceBalanced Crystalloid SolutionDexamethasoneFosaprepitantGranisetronMagnesium sulfatePotassium chlorideSubstanceBalanced Crystalloid SolutionDexamethasoneFosaprepitantGranisetronMagnesium sulfatePotassium chlorideSubstanceBalanced Crystalloid SolutionDexamethasoneFosaprepitantGranisetronMagnesium sulfatePotassium chlorideSubstanceBalanced Crystalloid SolutionDexamethasoneFosaprepitantGranisetronMagnesium sulfatePotassium chlorideNo. Substances6Protocol classificationTherapy classificationcurrent standardIntensityStandard doseTherapy indicationTherapy phaseTherapy intentioncurativeRisksEmetogenicity (MASCC/ESMO)HeadacheMucositisRash only studiesPublicationAuthorBhattasali ODiseaseSpeicheldrüsentumor, lokal fortgeschritten, nach oder ohne Debulking-OPOriginDepartment of Radiation Oncology, Kaiser Permanente Medical Center, Los Angeles, CaliforniaProtocols in Revision 1 protocol foundCisplatin 40 / Radiation, Salivary Gland Tumor (PID1699 V1.1)
